全球β地中海贫血检测市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测

预计全球β地中海贫血检测市场需求将从2022年的5018.3亿美元增至2030年的近12146.3亿美元，2023-2030年研究期间复合年增长率为9.2%。

β地中海贫血是一种血液疾病。这是一种遗传性疾病，身体产生的血红蛋白比平常少。血红蛋白是一种含有铁的蛋白质，存在于红细胞中；血红蛋白的主要功能是将氧气输送到全身的细胞。 β地中海贫血会导致大量血细胞被破坏。该病的特点是贫血、呼吸短促、疲劳、心跳加快、烦躁、黄疸和生长缓慢。 β地中海贫血检测包括输血和铁螯合疗法。

市场动态：

地中海贫血患病率的增加可能是市场增长的主要贡献者。影响β地中海贫血市场增长率的另一个重要因素是医疗保健支出的增加。此外，早期基因检测和咨询采用率的上升将促进市场增长。此外，政府提高地中海贫血意识的措施可能会推动市场增长。此外，研发活动的增加和有效治疗方法的推出提供了利润丰厚的市场机会。然而，与治疗相关的高成本可能会限制市场增长。

该研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球β地中海贫血检测市场的各个细分市场进行了包容性评估。 β地中海贫血检测行业的增长和趋势为本研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲的β地中海贫血测试市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。 β地中海贫血检测市场的主要参与者包括 MedGenome、3B BlackBio Biotech India Limited、Bio-Rad Laboratories Inc.、ViennaLab Diagnostics、Thermo Fisher Scientific Inc.、PerkinElmer Inc.、BioMedomics Inc.、Asper Biogene、Tosoh Bioscience Inc.。该部分包含竞争格局的整体视图，其中包括各种战略发展，例如关键併购、未来能力、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何定制要求，请写信给我们。我们的研究团队可以根据您的需求提供定制报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市场亮点
• 全球市场概况

第 3 章：β 地中海贫血测试 - 行业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 行业动态
• 波特五力分析
• 市场吸引力分析
  • 按产品分類的市场吸引力分析
  • 按技术分類的市场吸引力分析
  • 按类型分類的市场吸引力分析
  • 最终用户的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原材料分析
  • 原材料清单
  • 原料厂商清单
  • 主要原材料价格走势
• 潜在买家名单
• 营销渠道
  • 直效行销
  • 间接营销
  • 营销渠道发展趋势

第 5 章：COVID-19 爆发的影响分析

第 6 章：全球 β 地中海贫血测试市场分析：按产品分类

• 按产品概述
• 历史和预测数据
• 按产品分析
• 套件
• 耗材

第 7 章：全球 β 地中海贫血测试市场分析：按技术分类

• 按技术概述
• 历史和预测数据
• 按技术分析
• 产前诊断
• 全血细胞计数
• DNA检测
• 其他的

第 8 章：全球 β 地中海贫血测试市场分析：按类型

• 按类型概述
• 历史和预测数据
• 按类型分析
• 重型地中海贫血
• 中间型地中海贫血

第 9 章：全球 β 地中海贫血测试市场分析：按最终用户分类

• 最终用户概述
• 历史和预测数据
• 最终用户分析
• 医院和专科诊所
• 诊断中心
• 其他的

第 10 章：全球 β 地中海贫血测试市场分析：按地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概述、历史和预测销售分析
  • 北美按细分市场销售分析
  • 北美按国家/地区销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概述、历史和预测销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家/地区销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 意大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概述、历史和预测销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳大利亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概述、历史和预测销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家/地区销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概述、历史和预测销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙特阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 11 章：β 地中海贫血测试公司的竞争格局

• β地中海贫血检测市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 12 章：公司简介

• 顶级公司股票分析
• 市场集中度
• MedGenome
• 公司简介
• 公司收入
• 产品
• 最近的发展
• 3B BlackBio Biotech India Limited
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Bio-Rad Laboratories Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• ViennaLab Diagnostics
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Thermo Fisher Scientific Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• PerkinElmer Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• BioMedomics Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Asper Biogene
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Tosoh Bioscience Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细信息和近期发展视情况而定，或者如果是私营公司，则可能不包括在内

The global demand for Beta Thalassemia Testing Market is presumed to reach the market size of nearly USD 1214.63 BN by 2030 from USD 501.83 BN in 2022 with a CAGR of 9.2% under the study period 2023 - 2030.

Beta thalassemia is a type of blood disorder. This is a genetic disease in which the body produces less haemoglobin than usual. Haemoglobin is a protein containing iron and is present in red blood cells; the major function of haemoglobin is to carry oxygen to the body cells throughout the body. Beta thalassemia causes a huge number of blood cells to be destroyed. The condition is characterized by anemia, shortness of breath, fatigue, fast heartbeat, irritability, jaundice, and slow growth. Beta thalassemia testing consists of blood transfusions and iron chelation therapy.

MARKET DYNAMICS:

The increase in the prevalence of thalassemia may be a major contributor to market growth. Another significant factor influencing the beta thalassemia market growth rate is the rising healthcare expenditure. Also, the rise in the adoption rate of early genetic testing and counselling will boost market growth. Moreover, government measures to raise awareness of thalassemia may propel market growth. Furthermore, increased R&D activities and the launch of effective treatments offer lucrative market opportunities. However, the high cost associated with the treatment may limit the market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of beta thalassemia testing. The growth and trends of beta thalassemia testing industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the beta thalassemia testing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Kits
• Consumables

By Technology

• Prenatal Diagnosis
• Complete Blood Count
• Dna Testing
• Others

By Type

• Thalassemia Major
• Thalassemia Intermedia

By End-User

• Hospitals & Specialty Clinics
• Diagnostics Centers
• Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Beta Thalassemia Testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the beta thalassemia testing market include MedGenome, 3B BlackBio Biotech India Limited, Bio-Rad Laboratories Inc., ViennaLab Diagnostics, Thermo Fisher Scientific Inc., PerkinElmer Inc., BioMedomics Inc., Asper Biogene, Tosoh Bioscience Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . BETA THALASSEMIA TESTING - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Technology
  • 3.7.3 Market Attractiveness Analysis By Type
  • 3.7.4 Market Attractiveness Analysis By End-user
  • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY PRODUCT

• 6.1 Overview by Product
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Product
• 6.4 Kits Historic and Forecast Sales by Regions
• 6.5 Consumables Historic and Forecast Sales by Regions

7 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY TECHNOLOGY

• 7.1 Overview by Technology
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Technology
• 7.4 Prenatal Diagnosis Historic and Forecast Sales by Regions
• 7.5 Complete Blood Count Historic and Forecast Sales by Regions
• 7.6 DNA Testing Historic and Forecast Sales by Regions
• 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY TYPE

• 8.1 Overview by Type
• 8.2 Historical and Forecast Data
• 8.3 Analysis by Type
• 8.4 Thalassemia Major Historic and Forecast Sales by Regions
• 8.5 Thalassemia Intermedia Historic and Forecast Sales by Regions

9 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY END-USER

• 9.1 Overview by End-user
• 9.2 Historical and Forecast Data
• 9.3 Analysis by End-user
• 9.4 Hospitals & Specialty Clinics Historic and Forecast Sales by Regions
• 9.5 Diagnostics Centers Historic and Forecast Sales by Regions
• 9.6 Others Historic and Forecast Sales by Regions

10 . GLOBAL BETA THALASSEMIA TESTING MARKET ANALYSIS BY GEOGRAPHY

• 10.1. Regional Outlook
• 10.2. Introduction
• 10.3. North America Sales Analysis
  • 10.3.1. Overview, Historic and Forecast Sales Analysis
  • 10.3.2. North America By Segment Sales Analysis
  • 10.3.3. North America By Country Sales Analysis
  • 10.3.4. United State Sales Analysis
  • 10.3.5. Canada Sales Analysis
  • 10.3.6. Mexico Sales Analysis
• 10.4. Europe Sales Analysis
  • 10.4.1. Overview, Historic and Forecast Sales Analysis
  • 10.4.2. Europe by Segment Sales Analysis
  • 10.4.3. Europe by Country Sales Analysis
  • 10.4.4. United Kingdom Sales Analysis
  • 10.4.5. France Sales Analysis
  • 10.4.6. Germany Sales Analysis
  • 10.4.7. Italy Sales Analysis
  • 10.4.8. Russia Sales Analysis
  • 10.4.9. Rest Of Europe Sales Analysis
• 10.5. Asia Pacific Sales Analysis
  • 10.5.1. Overview, Historic and Forecast Sales Analysis
  • 10.5.2. Asia Pacific by Segment Sales Analysis
  • 10.5.3. Asia Pacific by Country Sales Analysis
  • 10.5.4. China Sales Analysis
  • 10.5.5. India Sales Analysis
  • 10.5.6. Japan Sales Analysis
  • 10.5.7. South Korea Sales Analysis
  • 10.5.8. Australia Sales Analysis
  • 10.5.9. Rest Of Asia Pacific Sales Analysis
• 10.6. Latin America Sales Analysis
  • 10.6.1. Overview, Historic and Forecast Sales Analysis
  • 10.6.2. Latin America by Segment Sales Analysis
  • 10.6.3. Latin America by Country Sales Analysis
  • 10.6.4. Brazil Sales Analysis
  • 10.6.5. Argentina Sales Analysis
  • 10.6.6. Peru Sales Analysis
  • 10.6.7. Chile Sales Analysis
  • 10.6.8. Rest of Latin America Sales Analysis
• 10.7. Middle East & Africa Sales Analysis
  • 10.7.1. Overview, Historic and Forecast Sales Analysis
  • 10.7.2. Middle East & Africa by Segment Sales Analysis
  • 10.7.3. Middle East & Africa by Country Sales Analysis
  • 10.7.4. Saudi Arabia Sales Analysis
  • 10.7.5. UAE Sales Analysis
  • 10.7.6. Israel Sales Analysis
  • 10.7.7. South Africa Sales Analysis
  • 10.7.8. Rest Of Middle East And Africa Sales Analysis

11 . COMPETITIVE LANDSCAPE OF THE BETA THALASSEMIA TESTING COMPANIES

• 11.1. Beta Thalassemia Testing Market Competition
• 11.2. Partnership/Collaboration/Agreement
• 11.3. Merger And Acquisitions
• 11.4. New Product Launch
• 11.5. Other Developments

12 . COMPANY PROFILES OF BETA THALASSEMIA TESTING INDUSTRY

• 12.1. Top Company Share Analysis
• 12.2. Market Concentration Rate
• 12.3. MedGenome
  • 12.3.1. Company Overview
  • 12.3.2. Company Revenue
  • 12.3.3. Products
  • 12.3.4. Recent Developments
• 12.4. 3B BlackBio Biotech India Limited
  • 12.4.1. Company Overview
  • 12.4.2. Company Revenue
  • 12.4.3. Products
  • 12.4.4. Recent Developments
• 12.5. Bio-Rad Laboratories Inc.
  • 12.5.1. Company Overview
  • 12.5.2. Company Revenue
  • 12.5.3. Products
  • 12.5.4. Recent Developments
• 12.6. ViennaLab Diagnostics
  • 12.6.1. Company Overview
  • 12.6.2. Company Revenue
  • 12.6.3. Products
  • 12.6.4. Recent Developments
• 12.7. Thermo Fisher Scientific Inc.
  • 12.7.1. Company Overview
  • 12.7.2. Company Revenue
  • 12.7.3. Products
  • 12.7.4. Recent Developments
• 12.8. PerkinElmer Inc.
  • 12.8.1. Company Overview
  • 12.8.2. Company Revenue
  • 12.8.3. Products
  • 12.8.4. Recent Developments
• 12.9. BioMedomics Inc.
  • 12.9.1. Company Overview
  • 12.9.2. Company Revenue
  • 12.9.3. Products
  • 12.9.4. Recent Developments
• 12.10. Asper Biogene
  • 12.10.1. Company Overview
  • 12.10.2. Company Revenue
  • 12.10.3. Products
  • 12.10.4. Recent Developments
• 12.11. Tosoh Bioscience Inc.
  • 12.11.1. Company Overview
  • 12.11.2. Company Revenue
  • 12.11.3. Products
  • 12.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product (USD MN)
• Kits Market Sales by Geography (USD MN)
• Consumables Market Sales by Geography (USD MN)
• Analysis Market by Technology (USD MN)
• Prenatal Diagnosis Market Sales by Geography (USD MN)
• Complete Blood Count Market Sales by Geography (USD MN)
• DNA Testing Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by Type (USD MN)
• Thalassemia Major Market Sales by Geography (USD MN)
• Thalassemia Intermedia Market Sales by Geography (USD MN)
• Analysis by End-user (USD MN)
• Hospitals & Specialty Clinics Market Sales by Geography (USD MN)
• Diagnostics Centers Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Beta Thalassemia Testing Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Beta Thalassemia Testing Report
• Market Research Process
• Market Research Methodology
• Global Beta Thalassemia Testing Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product
• Market Attractiveness Analysis by Technology
• Market Attractiveness Analysis by Type
• Market Attractiveness Analysis by End-user
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product (USD MN)
• Kits Market Sales by Geography (USD MN)
• Consumables Market Sales by Geography (USD MN)
• Global Market Analysis by Technology (USD MN)
• Prenatal Diagnosis Market Sales by Geography (USD MN)
• Complete Blood Count Market Sales by Geography (USD MN)
• DNA Testing Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by Type (USD MN)
• Thalassemia Major Market Sales by Geography (USD MN)
• Thalassemia Intermedia Market Sales by Geography (USD MN)
• Global Market Analysis by End-user (USD MN)
• Hospitals & Specialty Clinics Market Sales by Geography (USD MN)
• Diagnostics Centers Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.